SIGMA provides leading-edge diabetes treatment resources to our member community, including research spotlights, key opinion leader presentation videos, diabetes technology podcasts, and more.
Evidence-based guideline recommendations based on a review of clinical evidence, expertise, and informal consensus, according to established AACE protocol for guideline development.
This presentation provides an in-depth overview of the clinical benefits and features of Dexcom RT-CGM. Hear about the latest clinical evidence for RT-CGM in T2D, learn about remote monitoring and the benefits of sharing CGM data, how RT-CGM can benefit your patients and gain practical experience using case-based learning.
Watch a preview of the Dexcom Product Theater presented at ADA's 81st Scientific Sessions. Hear from the experts regarding the broader clinical use of Dexcom CGM, and its application for therapetutic guidance and intervention for people with T2D.
This presentation will highlight the International Consensus Guidelines on time in range (TIR) and share how you can incorporate TIR and other CGM metrics into your diabetes management discussions with people living with diabetes.
See highlights from the presentation by Lori Lemoine, DNP, on the role of real-time continuous glucose monitoring (RT-CGM) in optimizing diabetes treatment.
